Article Type
Changed
Mon, 12/10/2018 - 16:09
Display Headline
Irritable bowel syndrome: New tools and insights for the primary care physician
Roundtable discussion
Article PDF
Author and Disclosure Information

Edy E. Soffer, MD, Moderator
Head, Center for GI Motility Disorders, Department of Gastroenterology and Hepatology,
Cleveland Clinic Foundation, Cleveland, Ohio

Stephen Brunton, MD
Director of Faculty Development, Stamford Hospital/Columbia University, Family Practice Residency Program, Stamford, Connecticut

J. Harry Isaacson, MD
Vice Chairman, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Kevin W. Olden, MD
Associate Professor of Medicine, Division of Gastroenterology, Mayo Clinic Scottsdale, Scottsdale, Arizona

Bo Shen, MD
Associate Staff, Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, Ohio

Dr. Olden indicated that he is a consultant for Novartis Pharmaceuticals and GlaxoSmithKline.

Dr. Soffer indicated that he is a consultant for Impulse Dynamics.

Drs. Brunton, Isaacson, and Shen have indicated that they have no relationship that, in the context of their presentations could be perceived as a potential conflict of interest.

Publications
Page Number
S8-S20
Author and Disclosure Information

Edy E. Soffer, MD, Moderator
Head, Center for GI Motility Disorders, Department of Gastroenterology and Hepatology,
Cleveland Clinic Foundation, Cleveland, Ohio

Stephen Brunton, MD
Director of Faculty Development, Stamford Hospital/Columbia University, Family Practice Residency Program, Stamford, Connecticut

J. Harry Isaacson, MD
Vice Chairman, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Kevin W. Olden, MD
Associate Professor of Medicine, Division of Gastroenterology, Mayo Clinic Scottsdale, Scottsdale, Arizona

Bo Shen, MD
Associate Staff, Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, Ohio

Dr. Olden indicated that he is a consultant for Novartis Pharmaceuticals and GlaxoSmithKline.

Dr. Soffer indicated that he is a consultant for Impulse Dynamics.

Drs. Brunton, Isaacson, and Shen have indicated that they have no relationship that, in the context of their presentations could be perceived as a potential conflict of interest.

Author and Disclosure Information

Edy E. Soffer, MD, Moderator
Head, Center for GI Motility Disorders, Department of Gastroenterology and Hepatology,
Cleveland Clinic Foundation, Cleveland, Ohio

Stephen Brunton, MD
Director of Faculty Development, Stamford Hospital/Columbia University, Family Practice Residency Program, Stamford, Connecticut

J. Harry Isaacson, MD
Vice Chairman, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Kevin W. Olden, MD
Associate Professor of Medicine, Division of Gastroenterology, Mayo Clinic Scottsdale, Scottsdale, Arizona

Bo Shen, MD
Associate Staff, Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, Ohio

Dr. Olden indicated that he is a consultant for Novartis Pharmaceuticals and GlaxoSmithKline.

Dr. Soffer indicated that he is a consultant for Impulse Dynamics.

Drs. Brunton, Isaacson, and Shen have indicated that they have no relationship that, in the context of their presentations could be perceived as a potential conflict of interest.

Article PDF
Article PDF
Related Articles
Roundtable discussion
Roundtable discussion
Page Number
S8-S20
Page Number
S8-S20
Publications
Publications
Article Type
Display Headline
Irritable bowel syndrome: New tools and insights for the primary care physician
Display Headline
Irritable bowel syndrome: New tools and insights for the primary care physician
Citation Override
Cleveland Clinic Journal of Medicine 2003 June;70(suppl 2):S8-S20
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media